Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MannKind
MannKind
MannKind Evenly Poised
Yahoo/Zacks
Sat, 09/11/10 - 11:37 am
MannKind
investors
21 Drugs Facing FDA Approval Decisions
TheStreet.com
Tue, 08/31/10 - 12:05 pm
FDA
Questcor Pharmaceuticals
Savient
Alkermes
Arena Pharmaceuticals
Roche
Novartis
Hospira
Human Genome
Alexza
Jazz Pharmaceuticals
Biodel
Amylin
Eli Lilly
Vivus
Avanir
Cadence Pharmaceuticals
Amgen
Cumberland
Orexigen
MannKind
Bristol-Myers Squibb
These Are the Top 10 Pharma Underperform Calls
Motley Fool
Thu, 08/26/10 - 08:03 pm
Dendreon
Human Genome
Targacept
Vanda
Pharmacyclics
Acorda Therapeutics
MannKind
Which biotechs are the least efficient?
Fierce Biotech
Fri, 08/20/10 - 12:53 pm
MannKind
Orexigen
Aastrom
Hemispherx
Cell Therapeutics
Mannkind falls on securities offering
Marketwatch
Tue, 08/17/10 - 12:07 pm
MannKind
stock offering
MannKind / Seaside 88: Not Good News for Investors
Seeking Alpha
Thu, 08/12/10 - 11:33 am
MannKind
diabetes
Afrezza
Seaside 88
financing
Technically, MannKind Is a Buy
Motley Fool
Wed, 08/11/10 - 11:03 am
diabetes
inhaled insulin
MannKind
Afrezza
MannKind 2Q loss narrows on lower costs
Yahoo/AP
Mon, 08/2/10 - 10:30 am
MannKind
earnings
Will MannKind's Afrezza Succeed Where Pfizer's Exubera Failed?
Seeking Alpha
Mon, 07/26/10 - 11:13 am
Pfizer
MannKind
Afrezza
diabetes
inhaled insulin
Good News for MannKind
Yahoo/Zacks
Sat, 07/24/10 - 03:05 pm
Afrezza
MannKind
inhaled insulin
diabetes
Biotech Stock Mailbag: Exact Sciences
TheStreet.com
Fri, 07/23/10 - 07:16 am
EXACT Sciences
MannKind
Gilead Sciences
Somaxon
JNJ
Allos
Cell Therapeutics
What’s Up with MannKind?
Barron's
Wed, 07/14/10 - 04:32 pm
MannKind
Afrezza
diabetes
inhaled insulin
Mannkind: Rodman & Renshaw Reiterates Buy on Afrezza Data
Barron's
Thu, 07/1/10 - 08:41 am
MannKind
Afrezza
diabetes
inhaled insulin
Diabetes Drug Development Pops and Drops
Motley Fool
Wed, 06/30/10 - 09:57 am
diabetes
Orexigen
Contrave
Avandia
GSK
Merck
Eli Lilly
Amylin
Novo Nordisk
JNJ
MannKind
Afrezza
Mannkind Falls Following Afrezza Presentation; Hapoalim Reiterates Sell
Barron's
Mon, 06/28/10 - 02:53 pm
MannKind
Afrezza
diabetes
inhaled insulin
Hapoalim
AFREZZA Suppresses Endogenous Glucose Production More Rapidly Than Currently Available Insulin Therapy
Yahoo/BusinessWire
Sun, 06/27/10 - 10:52 am
Afrezza
MannKind
diabetes
type 2 diabetes
Diabetes drug makers gain ahead of conference
MarketWatch
Sat, 06/26/10 - 09:13 am
Arca pharmaceutical index
MannKind
Amylin
Molecular Insight
diabetes
MannKind Bear Analysts Strike Again
Seeking Alpha
Wed, 06/16/10 - 08:23 am
MannKind
Afrezza
Eli Lilly
inhaled insulin
diabetes
Another Step Back For MannKind?
Pharmalot
Fri, 06/11/10 - 10:18 am
MannKind
inhaled insulin
diabetes
Afrezza
MannKind Jumps as Inhaled Insulin Shows Superior Data
Barron's
Thu, 06/10/10 - 01:00 pm
MannKind
inhaled insulin
Afrezza
diabetes
Pages
« first
‹ previous
…
17
18
19
20
21
22
23
24
25
next ›
last »